Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$8.04 - $9.0 $11,119 - $12,447
-1,383 Reduced 10.63%
11,623 $97,000
Q1 2023

May 15, 2023

SELL
$7.57 - $8.37 $12,710 - $14,053
-1,679 Reduced 11.43%
13,006 $105,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.06 $488 - $660
82 Added 0.56%
14,685 $117,000
Q3 2022

Nov 14, 2022

BUY
$5.63 - $7.5 $82,214 - $109,522
14,603 New
14,603 $89,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.